Gender differences in endowed chairs in Departments of Psychiatry and Behavioral Sciences from the top-10 NIH-funded medical schools in the US.

The current study examined gender differences in endowed chairs within Departments of Psychiatry and Behavioral Sciences across the top 10 NIH-funded Schools of Medicine. The names of full professors with and without endowed chairs were collected and a multivariable logistic regression model was constructed to predict having an endowed chair considering gender, primary degree, NIH funding, and citation number. Secondary analyses repeated the models separately for individuals holding an MD or MD/PhD versus those with a non-MD doctoral degree (i.e., PhD). There were 715 full professors (36% women) and 115 endowed chairs (35% women). When adjusting for primary degree type, funding, and citations, women were significantly more likely to hold an endowed chair than men. Secondary models indicated that findings differed based on primary degree type. Among those with an MD or MD/PhD, gender was not associated with holding an endowed chair while among faculty with a PhD, women full professors were significantly more likely to hold an endowed chair than men. These results diverge from a prior study of Departments of Medicine in which endowed chairs were found to favor men.
Competing Interests: Declaration of Competing Interest Dr. Roubinov is supported by grants unrelated to this study, including the National Institute of Mental Health (K23MH113709; R56MH127032) and the California Governor's Office of Planning and Research. Dr. Gold has no sources of funding or support to disclose that relate to this work. Lena Jia has no conflicts or sources of funding or support to disclose. Kent Griffith has conflicts or important funding sources that relate to this work. Priya Dahiya has no conflicts or sources of funding or support to disclose. Dr. Mangurian is supported by grants unrelated to this study including the National Institutes of Mental Health (R01MH112420), the Doris Duke Charitable Foundation (Grant 2015211), the California Health Care Foundation, Genentech, and United Health Care. She received one-time speaking honoraria from Uncommon Bold. Dr. Jagsi has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health care companies; she has received personal fees from Amgen and Vizient and grants for unrelated work from the National Institutes of Health, the Doris Duke Foundation, the Greenwall Foundation, the Komen Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium. She has served as an expert witness for Sherinian and Hasso and Dressman Benzinger LaVelle.
(Copyright © 2022. Published by Elsevier B.V.)